Nwk Group, Inc. Amgen Inc Transaction History

Nwk Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $12,138 - $15,423	53 Added 0.25%	21,205 $5.57 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $172,385 - $194,419	-768 Reduced 3.5%	21,152 $4.77 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $5.06 Million - $5.63 Million	21,920 New	21,920 $5.33 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1,642 - $1,826	-7 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1,384 - $1,699	7 New	7 $2,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $2,004 - $2,658	-11 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $2,081 - $2,675	11 New	11 $3,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.